TODDE, SERGIO CAMILLO
TODDE, SERGIO CAMILLO
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models
2023 Rainone P.; Valtorta S.; Villa C.; Todde S.; Cadamuro M.; Bertoli G.; Conconi D.; Lavitrano M.; Moresco R.M.
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approac
2022 Iannone M.N.; Stucchi S.; Turolla E.A.; Beretta C.; Ciceri S.; Chinello C.; Pagani L.; Todde S.; Ferraboschi P.
Evaluation of Radiotherapy associated with Temozolomide plus Metformin in a GBM immunocompetent microenvironment
2021 Salvatore, D; Valtorta, S; Bertoli, G; Todde, S; Iannone, M; Coliva, A; Toninelli, E; Spinelli, A; Zerbetto, F; Villa, S; Di Muzio, N; Moresco, R
Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma
2021 Valtorta, S; Lo Dico, A; Raccagni, I; Martelli, C; Pieri, V; Rainone, P; Todde, S; Zinnhardt, B; De Bernardi, E; Coliva, A; Politi, Ls; Viel, T; Jacobs, Ah; Galli, R; Ottobrini, L; Vaira, V; Moresco, Rm
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach
2021 Iannone, Mn; Stucchi, S; Turolla, Ea; Beretta, C; Ciceri, S; Chinello, C; Pagani, L; Todde, S; Ferraboschi, P
The evaluation of [18F]FDG and [18F]FLT radiotracers as potential biomarkers of early treatment outcome in triple negative breast cancer (TNBC)
2021 Rainone P.; Valtorta S.; Todde S.; Salvatore R.; Moresco R.M.
VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells
2015 Curtarello M.; Zulato E.; Nardo G.; Valtorta S.; Guzzo G.; Rossi E.; Esposito G.; Msaki A.; Pasto A.; Rasola A.; Persano L.; Ciccarese F.; Bertorelle R.; Todde S.; Plebani M.; Schroer H.; Walenta S.; MuellerKlieser W.; Amadori A.; Moresco R.M.; Indraccolo S.
Assessing cancer metabolic remodeling in animal models using PET imaging
2013 Raccagni, I; Gaglio, D; Valtorta, S; Belloli, S; Di Grigoli, G; Vanoni, M; Mastroianni, F; Todde, S; Alberghina, L; Moresco, R M
Automated production of copper radioisotopes and preparation of high specific activity [(64)Cu]Cu-ATSM for PET studies.
2010 Matarrese M. ; Bedeschi P. ; Scardaoni R. ; Sudati F. ; Savi A. ; Pepe A. ; Masiello V. ; Todde S. ; Gianolli L. ; Messa C. ; Fazio F.
Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals.
2010 Elsinga P ; Todde S ; Penuelas I ; Meyer G ; Farstad B ; FaivreChauvet A ; Mikolajczak R ; Westera G ; GmeinerStopar T ; Decristoforo C ; Radiopharmacy Committee of the EANM.
Measurements and evaluation of the risks due to external radiation exposures and to intake of activated elements for operational staff engaged in the maintenance of medical cyclotrons
2010 Calandrino, R; del Vecchio, A; Parisi, R; Todde, S; De Felice, P; Savi, A; Pepe, A; Mrskova, A
Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation.
2008 Moresco R.M. ; Lavazza T. ; Belloli S. ; Lecchi M. ; Pezzola A. ; Todde S. ; Matarrese M. ; Carpinelli A. ; Turolla E. ; Zimarino V. ; Popoli P. ; Malgaroli A. ; ;Fazio F.
Synthesis and carbon-11 labeling of (R)- and (S)-thionisoxetine, norepinephrine reuptake inhibitors, potential radioligands for positron emission tomography.
2007 Filannino M.A. ; Matarrese M. ; Turolla E.A. ; Masiello V. ; Moresco R.M. ; Todde S. ; Verza E. ; Magni F. ; Cattaneo A. ; Bachi A. ; Kienle M.G. ; Fazio F.
Decommissioning procedures for an 11 MeV self-shielded medical cyclotron after 16 years of working time
2006 Calandrino, R; del Vecchio, A; Savi, A; Todde, S; Griffoni, V; Brambilla, S; Parisi, R; Simone, G; Fazio, F
Improved synthesis and radiolabeling of [(11)C]MP4A, a suitable ligand for the investigation of the cholinergic system using PET
2006 Carpinelli, A; Magni, F; Cattaneo, A; Matarrese, M; Turolla, E; Todde, S; Bosso, N; Galli Kienle, M; Fazio, F
11C-Labelling of N-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide derivatives and evaluation as potential radioligands for PET imaging of dopamine D3 receptors
2005 Turolla, Ea; Matarrese, M; Belloli, S; Moresco, Rm; Simonelli, P; Todde, S; Fazio, F; Magni, F; Galli Kienle, M; Leopoldo, M; Berardi, F; Colabufo, Na; Lacivita, E; Perrone, R
In vivo imaging of adenosine A2a receptors in rat and primate brain using [11C]SCH442416.
2005 Moresco, Rm; Todde, S; Belloli, S; Simonelli, P; Panzacchi, A; Rigamonti, M; Gallikienle, M; Fazio, F
11C-Radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]zofenoprilat
2004 Matarrese, M; Salimbeni, A; Turolla, Ea; Turozzi, D; Moresco, Rm; Poma, D; Magni, F; Todde, S; Rossetti, C; Sciarrone, Mt; Bianchi, G; Kienle, Mg; Fazio, F
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models | 1-gen-2023 | Rainone P.; Valtorta S.; Villa C.; Todde S.; Cadamuro M.; Bertoli G.; Conconi D.; Lavitrano M.; Moresco R.M. | |
| Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approac | 1-gen-2022 | Iannone M.N.; Stucchi S.; Turolla E.A.; Beretta C.; Ciceri S.; Chinello C.; Pagani L.; Todde S.; Ferraboschi P. | |
| Evaluation of Radiotherapy associated with Temozolomide plus Metformin in a GBM immunocompetent microenvironment | 1-gen-2021 | Salvatore, D; Valtorta, S; Bertoli, G; Todde, S; Iannone, M; Coliva, A; Toninelli, E; Spinelli, A; Zerbetto, F; Villa, S; Di Muzio, N; Moresco, R | |
| Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma | 1-gen-2021 | Valtorta, S; Lo Dico, A; Raccagni, I; Martelli, C; Pieri, V; Rainone, P; Todde, S; Zinnhardt, B; De Bernardi, E; Coliva, A; Politi, Ls; Viel, T; Jacobs, Ah; Galli, R; Ottobrini, L; Vaira, V; Moresco, Rm | |
| Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach | 1-gen-2021 | Iannone, Mn; Stucchi, S; Turolla, Ea; Beretta, C; Ciceri, S; Chinello, C; Pagani, L; Todde, S; Ferraboschi, P | |
| The evaluation of [18F]FDG and [18F]FLT radiotracers as potential biomarkers of early treatment outcome in triple negative breast cancer (TNBC) | 1-gen-2021 | Rainone P.; Valtorta S.; Todde S.; Salvatore R.; Moresco R.M. | |
| VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells | 1-gen-2015 | Curtarello M.; Zulato E.; Nardo G.; Valtorta S.; Guzzo G.; Rossi E.; Esposito G.; Msaki A.; Pasto A.; Rasola A.; Persano L.; Ciccarese F.; Bertorelle R.; Todde S.; Plebani M.; Schroer H.; Walenta S.; MuellerKlieser W.; Amadori A.; Moresco R.M.; Indraccolo S. | |
| Assessing cancer metabolic remodeling in animal models using PET imaging | 1-gen-2013 | Raccagni, I; Gaglio, D; Valtorta, S; Belloli, S; Di Grigoli, G; Vanoni, M; Mastroianni, F; Todde, S; Alberghina, L; Moresco, R M | |
| Automated production of copper radioisotopes and preparation of high specific activity [(64)Cu]Cu-ATSM for PET studies. | 1-gen-2010 | Matarrese M. ; Bedeschi P. ; Scardaoni R. ; Sudati F. ; Savi A. ; Pepe A. ; Masiello V. ; Todde S. ; Gianolli L. ; Messa C. ; Fazio F. | |
| Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals. | 1-gen-2010 | Elsinga P ; Todde S ; Penuelas I ; Meyer G ; Farstad B ; FaivreChauvet A ; Mikolajczak R ; Westera G ; GmeinerStopar T ; Decristoforo C ; Radiopharmacy Committee of the EANM. | |
| Measurements and evaluation of the risks due to external radiation exposures and to intake of activated elements for operational staff engaged in the maintenance of medical cyclotrons | 1-gen-2010 | Calandrino, R; del Vecchio, A; Parisi, R; Todde, S; De Felice, P; Savi, A; Pepe, A; Mrskova, A | |
| Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation. | 1-gen-2008 | Moresco R.M. ; Lavazza T. ; Belloli S. ; Lecchi M. ; Pezzola A. ; Todde S. ; Matarrese M. ; Carpinelli A. ; Turolla E. ; Zimarino V. ; Popoli P. ; Malgaroli A. ; ;Fazio F. | |
| Synthesis and carbon-11 labeling of (R)- and (S)-thionisoxetine, norepinephrine reuptake inhibitors, potential radioligands for positron emission tomography. | 1-gen-2007 | Filannino M.A. ; Matarrese M. ; Turolla E.A. ; Masiello V. ; Moresco R.M. ; Todde S. ; Verza E. ; Magni F. ; Cattaneo A. ; Bachi A. ; Kienle M.G. ; Fazio F. | |
| Decommissioning procedures for an 11 MeV self-shielded medical cyclotron after 16 years of working time | 1-gen-2006 | Calandrino, R; del Vecchio, A; Savi, A; Todde, S; Griffoni, V; Brambilla, S; Parisi, R; Simone, G; Fazio, F | |
| Improved synthesis and radiolabeling of [(11)C]MP4A, a suitable ligand for the investigation of the cholinergic system using PET | 1-gen-2006 | Carpinelli, A; Magni, F; Cattaneo, A; Matarrese, M; Turolla, E; Todde, S; Bosso, N; Galli Kienle, M; Fazio, F | |
| 11C-Labelling of N-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide derivatives and evaluation as potential radioligands for PET imaging of dopamine D3 receptors | 1-gen-2005 | Turolla, Ea; Matarrese, M; Belloli, S; Moresco, Rm; Simonelli, P; Todde, S; Fazio, F; Magni, F; Galli Kienle, M; Leopoldo, M; Berardi, F; Colabufo, Na; Lacivita, E; Perrone, R | |
| In vivo imaging of adenosine A2a receptors in rat and primate brain using [11C]SCH442416. | 1-gen-2005 | Moresco, Rm; Todde, S; Belloli, S; Simonelli, P; Panzacchi, A; Rigamonti, M; Gallikienle, M; Fazio, F | |
| 11C-Radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]zofenoprilat | 1-gen-2004 | Matarrese, M; Salimbeni, A; Turolla, Ea; Turozzi, D; Moresco, Rm; Poma, D; Magni, F; Todde, S; Rossetti, C; Sciarrone, Mt; Bianchi, G; Kienle, Mg; Fazio, F |